China to label fentanyl as controlled substance | Inquirer News

China to label fentanyl as controlled substance

/ 10:49 AM December 02, 2018

China President Xi Jinping talks during a bilateral meeting with President Donald Trump, Saturday, Dec. 1, 2018 in Buenos Aires, Argentina. (AP Photo/Pablo Martinez Monsivais)

China’s President Xi Jinping talks during a bilateral meeting with President Donald Trump, Saturday, Dec. 1, 2018 in Buenos Aires, Argentina. (AP Photo/Pablo Martinez Monsivais)

BUENOS AIRES — China has agreed to label fentanyl a controlled substance after a meeting between President Donald Trump and Chinese President Xi Jinping. The deadly synthetic opioid is responsible for tens of thousands of U.S. drug deaths annually.

The White House says Xi agreed to the move, long sought by the U.S., during a dinner Saturday between the two leaders on the margins of the Group of 20 summit in Buenos Aires, Argentina.

Article continues after this advertisement

U.S. officials for years have been pressing the Chinese government to take a tougher stance against fentanyl, which is 50 times more powerful than heroin. Most U.S. supply of the drug is manufactured in China.

White House press secretary Sarah Sanders says the decision means that “people selling fentanyl to the United States will be subject to China’s maximum penalty under the law.”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: China, Drugs, Fentanyl, G20, News, Opioid, Trump, Xi Jinping

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.